ESPE Abstracts (2018) 89 FC7.1

ESPE2018 Free Communications Fetal, Neonatal Endocrinology and Metabolism (6 abstracts)

Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism

Maria Güemes a, , Sofia Rahman b , Nita Solanky b , Clare Gilbert a , Kate Morgan a , Pratik Shah a, & Khalid Hussain b,

aEndocrinology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; bSection of Genetics and Epigenetics in Health and Disease, Genetics and Genomic Medicine Programme, University College London Great Ormond Street Hospital Institute of Child Health, London, UK; 3Department of Pediatric Medicine, Division of Endocrinology, Sidra Medical & Research Center, Doha, Qatar

Backgound: There is insufficient knowledge about the characterisation of insulin, glucagon, amylin, pancreatic polypeptide (PP) and Pancreas/Duodenum Homeobox Protein 1 (PDX-1) in pancreatic tissue of children with diffuse (DCHI) and focal (FCHI) congenital hyperinsulinism (CHI).

Objective(s): To understand the expression profile and localisation of insulin, glucagon, amylin, PP and PDX-1 in pancreatic tissue of children with DCHI and FCHI.

Methods: Human paediatric pancreatic samples from normal (N: 2), FCHI (N: 2) and DCHI (N: 2) were obtained. For localisation of hormones, same-slide double staining immunohistochemistry was performed and images visualised under fluorescent microscopy. PDX-1 was chosen as a marker of endocrine tissue as it stains the nuclei of β-cells. Gene expression was analysed with SybrGreen quantitative Real-Time polymerase chain reaction (RTqPCR) in the same groups. RPL19 was used as the endogenous control gene.

Results: Immunohistochemistry did not show differences in localisation of the 5 peptides between controls, FCHI and DCHI. Amylin stains the same cells as PDX-1 in normal and all forms of CHI, therefore limited to the endocrine component of the pancreas. In all three groups of patients, insulin and amylin had a different distribution within the β-cell so they did not co-localise. In CHI tissue, amylin shows comparable fluorescence to controls, and so does PP that is localised in scarce amount in the islets. Gene expression studies (RTqPCR) showed higher expression of insulin and lower of glucagon in all CHI forms, as compared to controls; consistent with known plasma hormone concentrations. In CHI forms, the expression of amylin and PDX-1 do not parallel that of insulin. PP expression is comparable in controls and all CHI cases. Gene expression of both amylin and PP, demonstrated high variability between DCHI subjects, compared to FCHI and normal pancreas.

Conclusions: As opposed to previous reports in the literature that had not used same-slide double staining, our study shows no co-localisation of amylin and insulin in the β-cell. Localisation and expression of amylin in CHI is independent to that of insulin, potentially indicating a β-cell preserved mechanism to minimise hypoglycaemia. Based on the expression studies PP may not have an important role in glucose regulation in CHI.

Article tools

My recent searches

No recent searches.